Skip to Main Content

Paper Details

DNMT3A mutations occur early or late in patients with myeloproliferative neoplasms and mutation order influences phenotype.
Haematologica
93
2015
Author NameAffiliation
David C WedgeWellcome Trust Sanger Institute
Charlie E MassieCambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge
Peter J CampbellCambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, Addenbrooke's Hospital, UK Wellcome Trust Sanger Institute
  • 1 - 3

Datasets

Release 1.2